# Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)

> **NCT05553184** · NA · COMPLETED · sponsor: **Université de Sherbrooke** · enrollment: 12 (actual)

## Conditions studied

- Type 2 Diabetes
- Obesity

## Interventions

- **DRUG:** Formoterol Fumarate 12 micrograms Inhalation Powder
- **DRUG:** Nicotinic Acid 50 MG Oral Tablet
- **OTHER:** Acute Cold Exposure
- **DIAGNOSTIC_TEST:** Positron Emission Tomography (PET)
- **DIAGNOSTIC_TEST:** Indirect calorimetry
- **DIAGNOSTIC_TEST:** dual-energy x-ray absorptiometry (DEXA scan)
- **PROCEDURE:** Biopsy
- **PROCEDURE:** iv lines
- **PROCEDURE:** Electromyogram (EMG)

## Key facts

- **NCT ID:** NCT05553184
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-05
- **Primary completion:** 2023-05-29
- **Final completion:** 2023-05-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05553184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05553184, "Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05553184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*